Shanghai, China

Xiaomin Zhang

This inventor holds 11 USPTO granted patents and 11 published patent applications and 3 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Glaxo Group Limited, Jiangsu Hengrui Medicine Company Ltd.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaomin Zhang. Retrieved from https://idiyas.com/inventor/xiaomin-zhang-2ijekyio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 54.5

 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Xiaomin Zhang

Introduction

Xiaomin Zhang is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made remarkable advancements in drug development, particularly in the treatment of serious diseases.

Latest Patents

Among his latest patents is the "Fused pyridine ring derivative, preparation method therefor, and pharmaceutical use thereof." This patent describes a fused pyridine ring derivative represented by a specific general formula, along with its preparation method and pharmaceutical composition. It highlights the use of this derivative as a therapeutic agent, especially in the preparation of drugs aimed at preventing and/or treating HIV infection. Another notable patent is for "Anti-Aβ antibodies and antigen-binding fragments thereof." This invention involves murine, chimeric, or humanized anti-Abeta antibodies with a specific CDR region, along with their antigen-binding fragments and pharmaceutical compositions. It emphasizes the use of a humanized anti-Abeta antibody for developing drugs to treat diseases or disorders, such as Alzheimer's disease, caused by amyloid beta protein.

Career Highlights

Xiaomin Zhang has worked with notable companies in the pharmaceutical industry, including GlaxoSmithKline Intellectual Property Development Limited and Glaxo Group Limited. His experience in these organizations has contributed to his expertise in patent development and innovation in drug formulation.

Collaborations

Throughout his career, Xiaomin Zhang has collaborated with various professionals, including his coworkers Zehong Wan and Jian Wang. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical sector.

Conclusion

Xiaomin Zhang's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of treatments for critical health issues, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…